Category:Carboxamides
Appearance
class of chemical compounds: amides of carboxylic acids | |||||
| Upload media | |||||
| Instance of |
| ||||
|---|---|---|---|---|---|
| Subclass of | |||||
| Different from | |||||
| |||||
Subcategories
This category has the following 97 subcategories, out of 97 total.
- Carboxamide group (21 F)
A
- Acadesine (4 F)
- Advantame (5 F)
- Alacepril (5 F)
- Alpravizafone (2 F)
- Azasetron (1 F)
B
- Barusiban (2 F)
- Biocytin (1 F)
- Butyramides (empty)
C
- Caroxazone (2 F)
- Casopitant (1 F)
- Cefalonium (3 F)
- Chapman rearrangement (8 F)
- Chloracyzine (2 F)
- Chloroacetamide (4 F)
- Cinecromen (4 F)
- Ciraparantag (1 F)
- Clovamide (3 F)
- Coelenteramide (1 F)
- Coenzyme B (3 F)
- Cyanoacetamide (5 F)
- Cyflufenamid (3 F)
D
- Darifenacin (2 F)
- Diclocymet (3 F)
E
- Eluxadoline (2 F)
- Embutramide (8 F)
- Enzalutamide (7 F)
- ERDRP-0519 (3 F)
F
- Fluorocarfentanil (2 F)
- Fonturacetam (14 F)
- Furmecyclox (2 F)
G
- Glucuronamide (4 F)
- Glycidamide (3 F)
- GR-89696 (3 F)
H
- Hexythiazox (2 F)
- Hordatine A (4 F)
I
- Iodixanol (3 F)
- Iodoacetamide (7 F)
- Iopamidol (4 F)
J
- JZ-IV-10 (3 F)
K
- Ketoconazole (27 F)
L
- Lemborexant (5 F)
- Lipoamide (7 F)
- Lufuradom (2 F)
M
- Mandipropamid (8 F)
- Moguisteine (4 F)
N
- Neratinib (2 F)
O
- Otenabant (3 F)
- Overman rearrangement (14 F)
P
- Pantethine (2 F)
- Paritaprevir (3 F)
- Phenylacetamide (3 F)
- Pipacycline (4 F)
- Piperazinones (5 F)
R
- Ralmitaront (1 F)
- Rapastinel (5 F)
- RTI-7470-44 (1 F)
S
- S32212 (2 F)
- Sacubitril (8 F)
- Samidorphan (3 F)
- Selexipag (3 F)
- Sorafenib (9 F)
- Spirapril (2 F)
T
- Thiamphenicol (7 F)
- Tifluadom (4 F)
- Triazamate (6 F)
- Trichloroacetamide (2 F)
V
- Valeramides (empty)
- Vamidothion (4 F)
W
- WAY-317538 (4 F)
X
- XEN-D0101 (3 F)
Y
- Y-27632 (3 F)
Z
- Zanubrutinib (27 F)
Α
Media in category "Carboxamides"
The following 168 files are in this category, out of 168 total.
-
((phenylacetyl)amino)acetic acid.svg 201 × 95; 7 KB
-
2,2-Dibromo-2-cyanacetamide Structural Formula V1.svg 234 × 151; 7 KB
-
2-Amino-2,3-dimethylbutanamide.svg 335 × 245; 7 KB
-
2-Chloroethyl chloro-N-nitrosoacetamide chemical structure.png 356 × 274; 7 KB
-
2-Phenylacetoacetamide.svg 335 × 365; 9 KB
-
2d structure of 6-an.gif 290 × 166; 4 KB
-
3,4-dihydroxyphenylacetamide.svg 177 × 76; 11 KB
-
3-(3,4-dihydroxyphenyl)butyramide.svg 189 × 102; 12 KB
-
4-CMTB structure.png 883 × 625; 31 KB
-
8-Carboxamidocyclazocine.svg 975 × 650; 14 KB
-
A-836339 structure.png 201 × 183; 7 KB
-
A1APU structure.png 1,465 × 732; 60 KB
-
ABT-341.svg 512 × 282; 8 KB
-
ACES (buffer).png 737 × 400; 8 KB
-
ACES buffer.svg 560 × 225; 19 KB
-
Acid-CatAmideHydrolMarch.png 1,430 × 920; 67 KB
-
Acyl chloride via amide catalysis.png 1,703 × 591; 27 KB
-
Acylsulfonamide.svg 188 × 114; 4 KB
-
Amide example.png 1,490 × 389; 32 KB
-
Amide General Formulae V.1.png 1,421 × 2,707; 30 KB
-
Amide on silica.png 318 × 157; 3 KB
-
Amide resonance v2.svg 754 × 286; 14 KB
-
Amide resonance.svg 754 × 222; 13 KB
-
Amide&Oxamide-Z&E.svg 348 × 119; 44 KB
-
Amide-group-structure.png 1,262 × 1,056; 57 KB
-
Amides.svg 244 × 60; 11 KB
-
Anthramycin.svg 512 × 265; 5 KB
-
Atropisomer Amide Example.png 1,490 × 377; 24 KB
-
Balcinrenone.svg 715 × 415; 22 KB
-
BAY2413555 structure.png 1,422 × 835; 56 KB
-
BAY2413555.svg 512 × 307; 15 KB
-
BAY60-6583 structure.png 472 × 462; 18 KB
-
Benzovindiflupyr.svg 512 × 175; 14 KB
-
Bromoacetamide.png 746 × 361; 8 KB
-
Bromoacetamide.svg 295 × 185; 5 KB
-
Butoctamide.svg 512 × 205; 4 KB
-
Chemical structure of trans and cis-amide. (Figure 2).png 1,186 × 461; 101 KB
-
Cis-trans-amides.png 669 × 240; 12 KB
-
Citenamide.svg 512 × 377; 12 KB
-
Citiolon előállítása.png 535 × 660; 33 KB
-
Claziprotamide.svg 473 × 249; 9 KB
-
CMLD-2 structure.png 711 × 813; 35 KB
-
CMLD-2.svg 512 × 604; 14 KB
-
CNX Chem 20 04 amide1 img.png 650 × 354; 21 KB
-
CNX Chem 20 04 amideLewis img.png 1,050 × 202; 23 KB
-
CPI-0610 structure.png 1,359 × 1,476; 19 KB
-
CRL-40,940 structure.png 342 × 270; 7 KB
-
CRL-40,940.svg 512 × 419; 4 KB
-
Crystal of N-(4-bromophenyl)acetamide.png 964 × 720; 718 KB
-
Cysmethynil skeletal.png 1,682 × 940; 76 KB
-
Dagrocorat.svg 1,445 × 995; 33 KB
-
Dichloroacetamide.png 603 × 440; 5 KB
-
Diethylacetamidomalonat rac-Phe.svg 634 × 98; 56 KB
-
Diethylacetamidomalonat Umpolung.svg 636 × 57; 56 KB
-
Dihexa structure.png 747 × 300; 13 KB
-
Draflazine.svg 512 × 245; 27 KB
-
EICAR.svg 645 × 400; 14 KB
-
Elunetirom.svg 820 × 345; 16 KB
-
Epoxomicin.svg 512 × 232; 7 KB
-
Esteramide aus 2-MGA.svg 542 × 389; 137 KB
-
Ethaboxam.svg 512 × 279; 14 KB
-
Ethanoic acid amide substructure.svg 91 × 69; 20 KB
-
Example Amide B.svg 147 × 103; 3 KB
-
Fenamistrobine.svg 614 × 246; 16 KB
-
Fertilysin.svg 980 × 240; 25 KB
-
FIGURE 3.png 312 × 394; 19 KB
-
FormationofAmides.png 1,808 × 288; 8 KB
-
Furaquinocin J.svg 511 × 231; 36 KB
-
Glesatinib skeletal.svg 512 × 252; 10 KB
-
Graf-Ritter Reaction HCN V1.svg 546 × 103; 8 KB
-
Graf-Ritter Reaction Mechanism V1.svg 264 × 373; 13 KB
-
Graf-Ritter Reaction MeCN V1.svg 547 × 103; 8 KB
-
GSK-588045.svg 1,045 × 395; 24 KB
-
Guineesine skeletal.svg 908 × 184; 5 KB
-
Hexadecanamide.png 2,552 × 364; 18 KB
-
Himeic acid B.png 2,309 × 704; 62 KB
-
Himeic acid F.png 2,184 × 560; 53 KB
-
Himeic acid G.png 2,320 × 704; 61 KB
-
Indantadol.svg 570 × 280; 1 KB
-
Indole-3-propionamide.svg 975 × 840; 21 KB
-
Iocetamic acid.png 1,003 × 466; 12 KB
-
Iprodione 200.svg 280 × 129; 12 KB
-
Irganox 1098 Strukturformel.svg 406 × 128; 27 KB
-
IS-159.svg 1,070 × 470; 27 KB
-
JDTic.svg 369 × 134; 40 KB
-
KAF156.svg 558 × 330; 13 KB
-
Ketene Reaktion3 V1.svg 526 × 166; 15 KB
-
Ketene Reaktion4 V1.svg 578 × 165; 16 KB
-
Ketene Reaktion5 V1.svg 583 × 165; 16 KB
-
L-371,257 structure.png 598 × 488; 20 KB
-
L-371,257.svg 512 × 399; 7 KB
-
Laucysteinamide A.svg 1,260 × 255; 14 KB
-
LG105.svg 420 × 292; 4 KB
-
LG120907.svg 420 × 292; 4 KB
-
LGK974 structure.png 1,505 × 628; 39 KB
-
LGK974.svg 512 × 193; 11 KB
-
LH-4 structure.svg 398 × 233; 17 KB
-
LPK-26 structure.png 512 × 272; 13 KB
-
LSN2463359.svg 715 × 435; 14 KB
-
MaleamicAcid.svg 106 × 30; 2 KB
-
Mandipropamid 200.svg 419 × 206; 12 KB
-
MECA.svg 700 × 280; 26 KB
-
Minzasolmin.png 1,713 × 943; 72 KB
-
Mioflazine.svg 512 × 245; 25 KB
-
Mizoribine.svg 640 × 400; 14 KB
-
Modafiendz.svg 590 × 485; 15 KB
-
Modafinil sulfone.svg 512 × 377; 4 KB
-
Motolimod structure.png 1,178 × 848; 33 KB
-
Motretinide.png 782 × 240; 12 KB
-
N-(2-(Diethylamino)ethyl)-1-benzothiophene-2-carboxamide.png 645 × 166; 6 KB
-
N-(D-glucos-1-yl)-L-asparagine.png 1,117 × 618; 41 KB
-
N-Benzoylphthalimide.svg 159 × 122; 11 KB
-
N-benzyl-1-methylpyridin-1-ium-4-carboxamide iodide.svg 207 × 95; 17 KB
-
N-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide.png 500 × 500; 4 KB
-
N-Isopropylmethacrylamid-Synthese.svg 531 × 100; 20 KB
-
N-Methyl-4-pyridone-3-carboxamide.svg 340 × 330; 8 KB
-
Nafadotride.svg 793 × 476; 2 KB
-
Naphthol AS-CA.svg 225 × 135; 23 KB
-
Naphthol AS-MX phosphate.svg 271 × 186; 32 KB
-
Napsagatran.png 2,496 × 1,278; 30 KB
-
Netropsin.svg 260 × 285; 43 KB
-
Nirtones.Acylation+Rearrangement.svg 598 × 282; 58 KB
-
Non-structure-like inhibitor ABT-341.png 318 × 165; 4 KB
-
Nooglutyl.svg 512 × 219; 7 KB
-
NYX-2925 structure.png 885 × 656; 36 KB
-
Ocadusertib.svg 836 × 288; 14 KB
-
Olmutinib skeletal.svg 512 × 225; 6 KB
-
OMT-28.svg 1,305 × 345; 16 KB
-
Orelabrutinib.svg 945 × 455; 21 KB
-
Oxadixyl.svg 226 × 257; 24 KB
-
Oxaz-via-SOCl2.png 1,552 × 806; 29 KB
-
Oxidation von Amiden mit N-Hydroxyphthalimid.svg 363 × 192; 37 KB
-
P-anisyl acetamide3D.png 666 × 365; 89 KB
-
Paraxazone.png 1,570 × 979; 19 KB
-
Paraxazone.svg 460 × 290; 11 KB
-
Paucine.svg 870 × 280; 12 KB
-
PEPA.png 435 × 189; 4 KB
-
Polyamid aus Dimerfettsäure und Diamin.svg 682 × 358; 25 KB
-
Propanoic acid amide substructure.svg 111 × 69; 23 KB
-
Prothoate synthesis.svg 1,563 × 322; 21 KB
-
Pydiflumetofen.svg 512 × 519; 4 KB
-
RD162.svg 665 × 341; 8 KB
-
Reaktion Imidchloride und Wasser V1.svg 590 × 128; 10 KB
-
Resonance Forms of an Amide.png 924 × 270; 11 KB
-
RO4929097.svg 1,670 × 840; 31 KB
-
Rotigaptide.svg 512 × 178; 44 KB
-
S32504 structure vertical flipped.svg 84 × 118; 7 KB
-
S32504 structure vertical.svg 84 × 119; 7 KB
-
SB-224289.svg 980 × 700; 25 KB
-
SB-616234.svg 1,040 × 695; 26 KB
-
Sintokamide A.svg 395 × 504; 12 KB
-
Sodium taurocholate.svg 605 × 291; 41 KB
-
SP4206 structure.png 1,562 × 861; 68 KB
-
SP4206.svg 512 × 295; 17 KB
-
Succinamide.png 535 × 277; 8 KB
-
Sulfobernsteinsäureamide mit 2-EHA.svg 687 × 128; 55 KB
-
Synthese von Nitrilotracetamid.svg 623 × 112; 61 KB
-
Tabilautide.svg 87,472 × 21,168; 31 KB
-
Tauromerism Amide Imido Acid.svg 236 × 71; 14 KB
-
TCAN via Trichloracetamid.svg 256 × 72; 25 KB
-
Telacebec.svg 329 × 163; 211 KB
-
Theonezolide A.svg 1,191 × 763; 81 KB
-
Therapeutic Compound targeting the HIV-1 Ribosomal Frameshift Signal.png 1,584 × 1,755; 144 KB
-
THPC.svg 285 × 375; 8 KB
-
Trelanserin.svg 945 × 470; 24 KB
-
Trifluoroacetamide.svg 95 × 81; 17 KB
-
Vamicamide v2.svg 395 × 420; 15 KB
-
WS-23 structure.png 570 × 527; 9 KB